{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:46:04Z","timestamp":1792399564845,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd014636","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000}}],"reference-count":144,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014636.pub2","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:08:06Z","timestamp":1785236886000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Albumin for people with liver cirrhosis and bacterial infections"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0047-5367","authenticated-orcid":false,"given":"Rosa G","family":"Simonetti","sequence":"additional","affiliation":[{"name":"Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Perricone","sequence":"additional","affiliation":[{"name":"Hepatology and Gastroenterology Unit; ASST Grande Ospedale Metropolitano Niguarda; Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrinka","family":"Nikolova","sequence":"additional","affiliation":[{"name":"Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Menon","sequence":"additional","affiliation":[{"name":"Cochrane France; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"10.1002\/14651858.CD014636.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/9781444341294.ch7","volume-title":"Sherlock's Diseases of the Liver and Biliary System","author":"Mc Cormick","year":"2011"},{"issue":"3","key":"10.1002\/14651858.CD014636.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"GBD 2017 Cirrhosis Collaborators","year":"2020","journal-title":"Lancet Gastroenterology & Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD014636.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1002\/14651858.CD014636.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMra2021808","article-title":"The evolving challenge of infections in cirrhosis","volume":"384","author":"Bajaj","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD014636.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1378\/chest.124.3.1016","article-title":"Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey","volume":"124","author":"Foreman","year":"2003","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD014636.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"5","key":"10.1002\/14651858.CD014636.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","article-title":"Clinical features and evolution of bacterial infection related acute-on-chronic liver failure","volume":"74","author":"Wong","year":"2021","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11901-014-0241-7","article-title":"Optimizing general management of acute variceal bleeding in cirrhosis","volume":"13","author":"Villanueva","year":"2014","journal-title":"Current Hepatology Reports"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka","year":"2020","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD014636.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jhep.2020.11.019","article-title":"PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis","volume":"74","author":"Trebicka","year":"2021","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD014636.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"7","key":"10.1002\/14651858.CD014636.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD014636.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jhep.2011.11.023","article-title":"Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study","volume":"56","author":"Pereira","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD014636.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cgh.2010.11.038","article-title":"Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis","volume":"9","author":"Tandon","year":"2011","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD014636.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fern\u00e1ndez","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD014636.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/eci.12701","article-title":"Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis","volume":"47","author":"Lutz","year":"2017","journal-title":"European Journal of Clinical Investigation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014636.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/liv.13645","article-title":"Infections complicating cirrhosis","volume":"38","author":"Piano","year":"2018","journal-title":"Liver International"},{"issue":"12 Suppl","key":"10.1002\/14651858.CD014636.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges and responses","volume":"10","author":"Levy","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.2147\/IDR.S290835","article-title":"Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health","volume":"13","author":"Majumder","year":"2020","journal-title":"Infection and Drug Resistance"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014636.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","article-title":"Management of bacterial infections in cirrhosis","volume":"56","author":"Fern\u00e1ndez","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/hep.25931","article-title":"Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis","volume":"56","author":"Arabi","year":"2012","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1748-1716.1975.tb05883.x","article-title":"Effect of insulin on albumin production and incorporation of 14C-leucine into proteins in isolated parenchymal liver cells from normal rats","volume":"94","author":"Dich","year":"1975","journal-title":"Acta Physiologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1748-1716.1976.tb10285.x","article-title":"Effect of glucagon on cyclic amp, albumin metabolism and incorporation of 14C-leucine into proteins in isolated parenchymal rat liver cells","volume":"97","author":"Dich","year":"1976","journal-title":"Acta Physiologica Scandinavica"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0016-5085(19)33181-6","article-title":"Albumin synthesis by human liver cells: its morphological demonstration","volume":"63","author":"Feldmann","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.99.2.125","article-title":"Synthesis of all plasma protein fractions except gamma globulins by the liver","volume":"99","author":"Miller","year":"1954","journal-title":"Journal of Experimental Medicine"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0021-9258(18)56538-8","article-title":"Production of radioactive serum albumin by liver slices","volume":"182","author":"Anfinsen","year":"1950","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5604\/01.3001.0012.0916","article-title":"New insights about albumin and liver disease","volume":"17","author":"Carvalho","year":"2018","journal-title":"Annals of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD014636.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD014636.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"British Journal of Surgery"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","article-title":"Albumin in decompensated cirrhosis: new concepts and perspectives","volume":"69","author":"Bernardi","year":"2020","journal-title":"Gut"},{"issue":"12","key":"10.1002\/14651858.CD014636.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41575-018-0045-2","article-title":"Novel perspectives in the management of decompensated cirrhosis","volume":"15","author":"Bernardi","year":"2018","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004039.pub2","article-title":"Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis","author":"Simonetti","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10138","key":"10.1002\/14651858.CD014636.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"91","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014636.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S0168-8278(09)60212-9","article-title":"Effects of albumin administration in patients with cirrhosis and bacterial infections other than spontaneous bacterial peritonitis. A randomized, controlled study","volume":"50","author":"Nazar","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial","volume":"62","author":"Th\u00e9venot","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0168-8278(14)60071-4","article-title":"Albumin infusion for bacterial infections other than spontaneous bacterial peritonitis in cirrhotic patients: a multicenter randomized controlled study (ALB-CIRINF study)","volume":"60","author":"Th\u00e9venot","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type I","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD014636.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llhai","year":"2008","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1002\/14651858.CD014636.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1186\/s13054-014-0702-y","article-title":"Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials","volume":"18","author":"Xu","year":"2014","journal-title":"Critical Care (London, England)"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jhep.2007.01.003","article-title":"Hepatology may have problems with putative surrogate outcome measures","volume":"46","author":"Gluud","year":"2007","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD014636.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/lt.25356","article-title":"Pro: the role of albumin in pre-liver transplant management","volume":"25","author":"Bernardi","year":"2019","journal-title":"Liver Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD014636.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000567.pub7","article-title":"Colloids versus crystalloids for fluid resuscitation in critically ill people","author":"Lewis","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jhep.2018.09.025","article-title":"MACHT \u2013 outpatient albumin infusions do not prevent complications of cirrhosis in patients on the liver transplant waiting list","volume":"69","author":"O\u2019Brien","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD014636.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/lt.25384","article-title":"Con: the unclear benefit of albumin","volume":"25","author":"O\u2019Brien","year":"2019","journal-title":"Liver Transplantation"},{"issue":"7192","key":"10.1002\/14651858.CD014636.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/bmj.318.7192.1214b","article-title":"More on albumin. Use of human albumin in UK fell substantially when systematic review was published","volume":"318","author":"Roberts","year":"1999","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD014636.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.dld.2020.05.047","article-title":"Efficacy and safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: a systematic review and meta-analysis","volume":"52","author":"Wong","year":"2020","journal-title":"Digestive and Liver Disease"},{"issue":"3","key":"10.1002\/14651858.CD014636.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jhep.2004.05.009","article-title":"Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"41","author":"Fern\u00e1ndez","year":"2004","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD014636.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fern\u00e1ndez","year":"2005","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0060|cit60","first-page":"514","article-title":"Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients","volume":"88","author":"Salerno","year":"1993","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD014636.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","volume":"58","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"1468\u201383","DOI":"10.1007\/s12072.022-10374-z","article-title":"Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Bai","year":"2022","journal-title":"Hepatology International"},{"issue":"12","key":"10.1002\/14651858.CD014636.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"e33124","DOI":"10.7759\/cureus.33124","article-title":"Efficacy of intravenous albumin for spontaneous bacterial peritonitis infection among patients with cirrhosis: a meta-analysis of randomized control trials","volume":"14","author":"Batool","year":"2022","journal-title":"Cureus"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/apt.17344","article-title":"Meta-analysis: efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis","volume":"57","author":"Leache","year":"2023","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD014636.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1111\/jgh.14791","article-title":"Albumin for cirrhotic patients with extraperitoneal infections: a meta-analysis","volume":"34","author":"Le\u00e3o","year":"2019","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/HMER.S264231","article-title":"Albumin administration is efficacious in the management of patients with cirrhosis: a systematic review of the literature","volume":"12","author":"Zaccherini","year":"2020","journal-title":"Hepatic Medicine: Evidence and Research"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0068|cit68","first-page":"321\u201338","article-title":"Use of intravenous albumin. A guideline from the International Collaboration for Transfusion Medicine guidelines","volume":"166","author":"Callum","year":"2024","journal-title":"Chest"},{"issue":"23","key":"10.1002\/14651858.CD014636.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2025.3792","article-title":"Use of intravenous albumin","volume":"333","author":"Fuest","year":"2025","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD014636.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"100785","DOI":"10.1016\/j.jhepr.2023.100785","article-title":"Use of albumin infusion for cirrhosis-related complications: an international position statement","volume":"5","author":"Bai","year":"2023","journal-title":"JHEP Reports"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0071|cit71","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"216e","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"e081904","DOI":"10.1136\/bmj-2024-081904","article-title":"Core GRADE 2: choosing the target of certainty rating and assessing imprecision","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0076|cit76","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Chapter 10: Analysing data and undertaking meta-analyses [last updated November 2024]. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024) Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0077|cit77","unstructured":"Higgins JP Eldridge S Chapter 23: Including variants on randomized trials. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024) Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0078|cit78","unstructured":"International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH) ICH Harmonised Guideline Integrated addendum to ICH EG (R1) guideline for good clinical practice EG (R2) https:\/\/www.database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"issue":"8","key":"10.1002\/14651858.CD014636.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0080|cit80","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies [last updated March 2025]. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024) Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD014636.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA Statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0082|cit82","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Technical Supplement to Chapter 4: Searching for and selecting studies (last updated September 2024). Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). C ochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024) Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0083|cit83","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Chapter 6: Choosing effect measures and computing estimates of effect. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024) Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0084|cit84","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0085|cit85","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0086|cit86","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence [last updated August 2023]. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024) Available from http:\/\/www.cochrane.org\/handbook"},{"issue":"11","key":"10.1002\/14651858.CD014636.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"9128","key":"10.1002\/14651858.CD014636.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"35","key":"10.1002\/14651858.CD014636.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD014636.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD014636.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: the ROBES meta-epidemiologic study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD014636.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jama.273.5.408","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"7644","key":"10.1002\/14651858.CD014636.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0094|cit94","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024) Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"I4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0096|cit96","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024) Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"7211","key":"10.1002\/14651858.CD014636.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"issue":"7121","key":"10.1002\/14651858.CD014636.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0099|cit99","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis [last updated August 2024]. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024) Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0100|cit100","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods [last updated October 2019]. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024) Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0102|cit102","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from www.gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7650","key":"10.1002\/14651858.CD014636.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction \u2013 GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence \u2013 study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD014636.pub2-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence \u2013 publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD014636.pub2-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence \u2013 imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD014636.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence \u2013 inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD014636.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence \u2013 indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD014636.pub2-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables \u2013 binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles \u2013 continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD014636.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 15. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jclinepi.2017.05.005","article-title":"GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence","volume":"87","author":"Guyatt","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD014636.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jclinepi.2013.02.004","article-title":"The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses","volume":"66","author":"Mustafa","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jclinepi.2015.12.006","article-title":"Improving GRADE evidence tables part 3: detailed guidance for explanatory footnotes supports creating and understanding GRADE certainty in the evidence judgments","volume":"74","author":"Santesso","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0120|cit120","unstructured":"To study efficacy of albumin in cirrhosis with spontaneous bacterial peritonitis at low risk for AKI development www.clinicaltrials.gov\/study\/NCT04437810"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0121|cit121","unstructured":"20% albumin vs. balanced salt solution as resuscitation fluid in cirrhosis with sepsis induced hypotension www.clinicaltrials.gov\/study\/NCT05441878"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0122|cit122","unstructured":"Efficacy of 5% albumin v\/s plasmalyte in combination with 20% albumin for fluid resuscitation in cirrhosis with sepsis induced hypotension www.clinicaltrials.gov\/study\/NCT06076330"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/00365520902719273","article-title":"Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"44","author":"Chen","year":"2009","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"40","key":"10.1002\/14651858.CD014636.pub2-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cgh.2019.07.055","article-title":"Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis","volume":"18","author":"Fern\u00e1ndez","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0125|cit125","first-page":"S253","article-title":"Albumin administration in the prevention of hepatorenal syndrome (HRS) and death in patients with advanced cirrhosis and non-SBP infections","volume":"68","author":"Fernandez","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD014636.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.jceh.2015.07.244","article-title":"Albumin as an adjuvant to antibiotic therapy in non-SBP infections in patients with chronic liver failure - a prospective randomized study","volume":"5","author":"Lone","year":"2015","journal-title":"Journal of Clinical and Experimental Hepatology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2022.03.043","article-title":"A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension (ALPS trial)","volume":"77","author":"Maiwall","year":"2022","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12072-021-10164-z","article-title":"Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial","volume":"15","author":"Philips","year":"2021","journal-title":"Hepatology International"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014636.pub2-BIB0129|cit129","first-page":"261A","article-title":"Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis-induced hypotension \u2013 a randomized controlled trial \u2013 fluid resuscitation in septic shock in cirrhosis (FRISC protocol)","volume":"62","author":"Philips","year":"2015","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"7","key":"10.1002\/14651858.CD014636.pub2-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/MEG.0000000000000635","article-title":"Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis","volume":"28","author":"Salman","year":"2016","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1443-9573.2002.00062.x","article-title":"Effect of albumin infusion on preventing the deterioration of renal function in patients with spontaneous bacterial peritonitis","volume":"3","author":"Xue","year":"2002","journal-title":"Chinese Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajg.2012.06.003","article-title":"Evaluation of different therapeutic approaches for spontaneous bacterial peritonitis","volume":"13","author":"Abd Elaal","year":"2012","journal-title":"Arab Journal of Gastroenterology"},{"issue":"S4","key":"10.1002\/14651858.CD014636.pub2-BIB0133|cit133","first-page":"446A","article-title":"Effect of intravenous albumin (standard vs dose reduced regimen) on renal impairmenet and mortality in patients with cirrhosis and spontaneous bacterial peritonitis: a double blind randomized clinical trial - Interim analysis of the ALTERNATE study","volume":"50","author":"Araujo","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014636.pub2-BIB0134|cit134","first-page":"A52","article-title":"Effect of albumin infusion (low versus standard dose) on the nitric oxide and cytokine levels in plasma and ascitic fluid of spontaneous bacterial peritonitis patients","volume":"34","author":"Baruah","year":"2015","journal-title":"Indian Journal of Gastroenterology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD014636.pub2-BIB0135|cit135","first-page":"S45","article-title":"Impact of low dose albumin infuasion on outcome in patients with cirrhosis and sepsis - a randomized open label clinical trial","volume":"16","author":"Devisetty","year":"2022","journal-title":"Hepatology International"},{"issue":"4","key":"10.1002\/14651858.CD014636.pub2-BIB0136|cit136","doi-asserted-by":"publisher","first-page":"505\u201316","DOI":"10.1007\/s12664-023-01389-","article-title":"Tolerance of standard dose albumin infused over 6 hrs for treatment of spontaneous bacterial peritonitis-A randomized controlled trial","volume":"42","author":"Kar","year":"2023","journal-title":"Indian Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD014636.pub2-BIB0137|cit137","first-page":"52","article-title":"Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized prospective study","volume":"8","author":"Choi","year":"2002","journal-title":"Taehan Kan Hakhoe Chi [Korean Journal of Hepatology]"},{"issue":"1","key":"10.1002\/14651858.CD014636.pub2-BIB0138|cit138","first-page":"47","article-title":"Effect of albumin in cirrhotic patients with infections other than spontaneous bacterial peritonitis","volume":"28","author":"Brusoni","year":"2017","journal-title":"Gastroenterolog\u00eda Latinoamericana"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/CCM.0b013e3181ffe217","article-title":"The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis","volume":"39","author":"Delaney","year":"2011","journal-title":"Critical Care Medicine"},{"issue":"11","key":"10.1002\/14651858.CD014636.pub2-BIB0140|cit140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001208.pub4","article-title":"Human albumin solution for resuscitation and volume expansion in critically ill patients","author":"Roberts","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD014636.pub2-BIB0141|cit141","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000567.pub6","article-title":"Colloids versus crystalloids for fluid resuscitation in critically ill patients","author":"Perel","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD014636.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00134-014-3311-y","article-title":"Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethylstarch 130\/0.42 or Ringer's acetate","volume":"40","author":"Perner","year":"2014","journal-title":"Intensive Care Medicine"},{"key":"10.1002\/14651858.CD014636.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/hep.30412","article-title":"Management of sepsis in patients with cirrhosis: current evidence and practical approach","volume":"70","author":"Simonetto","year":"2019","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1002\/14651858.CD014636.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jclinepi.2013.08.005","article-title":"Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health","volume":"67","author":"O'Neill","year":"2014","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:21:27Z","timestamp":1792398087000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014636.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":144,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014636.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}